Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jun 3 2015

Full Issue

Bets On Health Care Paying Off For Investors

Despite high prices, shares of health care companies continue to soar. Elsewhere, an investor wins an arbitration award against UBS, the feds crack down on Medicare Advantage fraud and health insurer Anthem is offering workers free college tuition to entice new employees.

Reuters: Fund Managers Boost Bets On Health Care Even Amid High Prices

Last July, when Federal Reserve Chair Janet Yellen spurred a sell-off in healthcare stocks by saying that valuations in shares of biotech companies looked "stretched," portfolio manager Graham Tanaka saw an opportunity. After a year-long buying spree, he now has more than a quarter of his $17 million Tanaka Growth fund portfolio in healthcare companies such as Gilead Sciences Inc, up from just 5 percent at the start of last year. (Randall, 6/2)

The Wall Street Journal: Activist Investor Wins $2 Million Arbitration Award From UBS

An activist investor has won a $2 million arbitration award from UBS AG, which he said derailed his proxy fight against a health-care information systems company by calling a margin loan and selling almost 2.3 million shares he had in the business. (Rieker, 6/2)

The Fiscal Times: Medicare Advantage Fraud: Heat On Justice Dept. To Investigate

The way the federal government calculates benefits for the Medicare Advantage program has been under scrutiny for years—with reformists and health policy experts claiming that the formula used to calculate benefits can be easily inflated and potentially wastes billions of tax dollars a year. (Ehley, 6/2)

Bloomberg: Anthem Offers Free College As Newest Perk

Health insurer Anthem Inc. is the latest big employer to offer its workers a free college education. Anthem employees can sign up for online degrees in business and health care at the College for America at Southern New Hampshire University. About 34,000 of the company’s 55,000 workers haven’t graduated from college. (Tracer, 6/2)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF